Be Ready for JPM 2026

Strengthen Your Story

Limited Time Offer — Discount Expires Soon*

Corval Compass is a fast, affordable, and data-driven overview of your asset’s commercialization plan. In just days, you get a concise, discussion-ready summary built on Corval’s proven, tech-driven platform.

What’s included:

  • Presentation deck with a commercial plan customized to your asset, therapeutic area, and key milestones
    • Commercialization and launch roadmap in Gantt format detailing the key work streams, objectives, and deliverables vis a vis your clinical development and regulatory milestones—including all key functions (marketing, medical affairs, market access, communications, operations)
    • High-level starting point recommendations for key investments such as operational budget by function by year through launch
    • High-level starting point recommendations for building the organization such number of FTEs to hire by function by year through launch and related hiring budget
    • Executive summary of overall plan
  • Detailed review of your tailored Corval Compass with our commercialization expert and an opportunity to address questions

With the JPM Healthcare Conference 2026 fast approaching, Corval Compass is purpose-built to deliver a detailed summary of your asset, providing you and your team with the utmost confidence for partnership discussions.

Corval Compass Sample

Get Your Corval Compass Today

If you’re a US-based biopharma company with a drug or biologic in Phase 2 or 3, we’re here to get you ready for JPM 2026!

  • Rapid Readiness: Get a strategic snapshot of your asset’s commercial and launch plan in days, not weeks — ideal timing for JPM 2026 prep.
  • Discussion-Ready Insights: Present a credible, data-backed story that builds confidence with investors, partners, and potential collaborators.
  • Affordable Clarity: A low-lift, high-value deliverable designed for early-stage teams preparing to engage at major conferences and partnering meetings.
 
*Offer valid from October 30, 2025 through December 5, 2025. Corval Compass is powered by Corval’s patent-pending technology and decades of biopharma experience.
Reach Out Now to Get Started

We’re committed to your privacy. For more information, please see our Privacy Policy and Terms and Conditions.

We use cookies to improve user experience and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By using this website you consent to store on your device all the technologies described in our Privacy Policy.